Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Endoscopy
  •  Transplantation Medicine
  •  Renal Disease
  •  Hematology
  •  Nutrition and Food Science
  •  Ophthalmology
  •  Psychiatry and Mental Health
  •  Orthopedic Surgery


Citation: Ann Clin Case Rep. 2018;3(1):1488.DOI: 10.25107/2474-1655.1488

Somatostatin Receptor Scintigraphy with 111In- Pentetreotide for Detection of Atypical Metastatic Localization of a Midgut Neuroendocrine Tumor: A Case Study

Lyonel Belia, Eddy Glaude, Caroline Faes, Thibault Michelin, Mona Hedreville, Mathon Grégory, Ulises Jáuregui-Haza and Fritz-Line Vélayoudom-Céphise

Department of Endocrinologie, University Hospital of Pointe-à-Pitre, Cuba
Department of Endocrinologie, University of Havana, Cuba
Department of Endocrinologie, University of the French West Indies, Cuba

*Correspondance to: Fritz-Line VĂ©layoudom-CĂ©phise 

 PDF  Full Text Case Report | Open Access


A 49-year-old man was referred to the University Hospital of Pointe-à-Pitre for abdominal pains. He underwent a midgut neuroendocrine tumor (NET) resection 8 years ago. The computed tomography revealed multiple liver metastases. 111In-pentetreotide, SPECT/CT identified liver metastases and a suspect cardiac uptake. A cardiac magnetic resonance imaging confirmed a thickening of the bottom wall of the heart, measuring 24 mm compatible with a cardiac metastasis of the NET.111In-Pentetreotide SPECT/CT remains a good functional imaging compared to conventional somatostatin receptor scintigraphy to precise anatomical localization of NET metastases and could help to select the best morphological imaging to complete the staging of metastatic NET. The delayed detection of the cardiac metastasis did not allow setting up an effective management and the patient dead due to an uncommon hepatic metastasis compression of the heart.


Neuroendocrine tumor; Somatostatin receptor scintigraphy; 111In-pentetreotide

Cite the Article:

Belia L, Glaude L, Faes C, Michelin T, Hedreville M, Grégory M, et al. Somatostatin Receptor Scintigraphy with 111In-Pentetreotide for Detection of Atypical Metastatic Localization of a Midgut Neuroendocrine Tumor: A Case Study. Ann Clin Case Rep. 2018; 3: 1488.

Search Our Journal

Journal Indexed In

Articles in PubMed

Does Autoimmunity have a Role in Myoclonic Astatic Epilepsy? A Case Report of Voltage Gated Potassium Channel Mediated Seizures
 PubMed  PMC  PDF  Full Text
Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

A Case Report and Literature Review of Senile Myelodysplastic Syndrome with Mast Cell Hyperplasia
 Abstract  PDF  Full Text
A Case Report of Curing Major Depression Disorder Only via Light Therapy and Physical Therapy
 Abstract  PDF  Full Text
View More...